Resources
For the latest in biologics & tides, sign up for our monthly newsletter to be among the first to receive exclusive insights, in-depth market analyses, and expert articles directly to your inbox
A concise report featuring insights from the prominent thought leaders of Biologics 2024
Top R&D Stories of 2023
Through captivating articles, insight pieces, and spotlight interviews, we delve into the remarkable innovations, breakthroughs, and scientific marvels that have defined the landscape of research over the past year.
NextGen Therapeutics
FDA's AI Model Enhances Safety of Biosimilar Therapeutic Proteins
Thanks to the FDA's new AI-powered imaging tool, the safety profile of newly developed biosimilar therapeutic protiens may improve.
Antibody & Protein Engineering
Interview with Andrew Brown, Head of Process Development Sciences at Lonza
Andrew Brown, Head of Process Development Sciences at Lonza, talks about Lonza's approach to process development.
Subscribe to Our Newsletter
Sign up for our monthly newsletter to
keep up with all things biologics